The most useful thing to know first: Ozempic and Wegovy contain the same active molecule, semaglutide, from the same manufacturer. They are not competitors in the way two different drugs would be.
What differs is what each is approved for, and that difference drives everything downstream — the dosing schedule, what a clinician can prescribe you, and whether insurance pays.
| Ozempic | Wegovy | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Approved for | Type 2 diabetes | Chronic weight management |
| Maker | Novo Nordisk | Novo Nordisk |
| Maximum dose | Lower | Higher |
| Insurance treatment | Often covered for diabetes | Frequently excluded |
Why people are prescribed one and not the other
If you have type 2 diabetes, Ozempic is the on-label option and the one insurance is likeliest to cover. If your goal is weight management without diabetes, Wegovy is the product approved for that purpose.
Being prescribed Ozempic purely for weight loss is off-label use. It happens, it is legal for a clinician to do, and it is a decision that belongs to them — but it changes how insurance responds and it is worth understanding before you ask.
What neither is
Neither is a short course. Both are studied and prescribed as long-term treatment, and the trial data on stopping is consistent: most people regain a substantial share of lost weight. Deciding to start is really deciding whether you want to be on a medication for a long time.